BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Receivables

Latest receivables for LSBPW: $500M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$501.79M
↑ 12.97% YoYΔ $57.63M vs prior year quarter

Peer trimmed avg / median

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Receivables History

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) vs. peers: Receivables Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) FAQ

As of the most recent data (March 2025), LSBPW shows a receivables of $500M. That compares with $440M in the prior-year period — up 13.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSBPW's receivables is now $500M (was $440M) — a 13.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is outperforming or lagging.

Tracking LSBPW's receivables over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $500M That compares with $440M in the prior-year period — up 13.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $500M) with ownership activity and broader fundamentals.